Clinical Study

Iso-Osmolar Iodixanol Induces Less Increase in Circulating Endothelial Microparticles In Vivo and Less Endothelial Apoptosis In Vitro Compared with Low-Osmolar Iohexol

Table 1

Patients’ baseline characteristics.

VariatesGroup IGroup IIGroup III

505049/
Male, (%)28 (56.0)31 (62.0)37 (75.5)0.116
Age, years68.6 ± 8.868.6 ± 9.468.5 ± 9.50.998
BMI, kg/m225.1 ± 3.024.6 ± 2.624.9 ± 3.10.767
HBP, (%)41 (82.0)43 (86.0)35 (71.4)0.175
Smoking history, (%)18 (36.0)17 (34.0)24 (49.0)0.256
Family history, (%)33 (66.0)33 (66.0)25 (51.0)0.212
Total cholesterol, mmol/L4.1 ± 1.23.9 ± 0.93.9 ± 0.90.571
Total triglyceride, mmol/L1.3 ± 1.71.3 ± 1.71.3 ± 1.70.999
HDL-C, mmol/L1.2 ± 1.31.2 ± 1.21.2 ± 1.20.695
LDL-C, mmol/L2.3 ± 1.62.1 ± 1.32.0 ± 1.40.216
hsCRP, mg/L1.3 ± 4.31.8 ± 5.41.3 ± 4.00.495
Fasting blood glucose, mmol/L7.1 ± 1.47.2 ± 1.35.3 ± 1.2<0.001
Blood urea nitrogen, mmol/L5.3 (4.6, 6.5)6.0 (5.0, 7.6)5.1 (3.8, 6.1)0.003
Creatinine, µmol/L66.5 (59.8, 76.3)72.9 (62.5, 89.4)73.0 (62.0, 85.0)0.046
ALT, U/L18.5 (13.0, 25.8)17.5 (13.0, 25.0)18.0 (14.0, 23.5)0.694
AST, U/L19.5 (17.0, 23.3)19.0 (15.8, 23.3)20.0 (17.5, 23.5)0.209
CK-MB, ng/mL1.9 (1.1, 3.2)2.0 (1.3, 3.6)1.8 (1.2, 3.8)0.846
Troponin-T, ng/mL0.01 (0.01, 0.05)0.01 (0.00, 0.03)0.01 (0.00, 0.04)0.223
Lesion arteries, 2.0 (2.0, 3.0)3.0 (2.0, 4.0)2.0 (1.0, 3.0)0.151
Implanted stents, 1.0 (1.0, 1.0)1.0 (1.0, 2.0)1.0 (1.0, 2.0)0.388
Gensini Score27.7 ± 2.028.1 ± 2.428.7 ± 1.90.970
Volume of contrast media, mL150.0 (150.0, 150.0)150.0 (150.0, 150.0)150.0 (150.0,150.0)0.570

Normal data are represented by mean ± SD, nonnormal variates are repressed as median (interquartile range), and categorical variables are expressed as percentage. BMI: body mass index; HBP: high blood pressure; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; hsCRP: high sensitivity C-reactive protein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CK-MB: creatine kinase isoenzyme MB.